US

Utkarsh Singh

Active Director Director DIN 00705923
DIN 00705923 First appointment Sep 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Sep 2006
Shareholding value •••• Premium profile

About Utkarsh Singh

Data last updated:

Utkarsh Singh is a Director at Ravian Pharmaceuticals Limited (since 2021), Director at Fierce One Pharmaceuticals Private Limited (since 2021) and Director at Balaji Pharmatech Private Limited (since 2023). The companies operate in Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹13.16 Cr; the largest is Ravian Pharmaceuticals Limited at ₹8.28 Cr (FY 2025). Earlier, Utkarsh Singh was an Additional Director at Ravian Life Science Private Limited (2006–2022) and Director at Shahi Emergency Hospital Private Limited (from 2013).

DIN 00705923
Primary Designation Director
Industry Pharma
First Appointment 14 Sep 2006
Oldest Company Age 30 yrs
Largest company Ravian Pharmaceuticals Limited · ₹8.28 Cr (FY 2025)
Combined revenue ₹13.16 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ravian Pharmaceuticals Limited U24230BR1996PLC006971
Director04 Jul 20211996₹8.28 Cr (FY 2025)Active
Director16 Dec 20212021₹3.72 Cr (FY 2024)Active
Balaji Pharmatech Private Limited U28998UR2021PTC012735
Director18 Feb 20232021₹1.15 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ravian Life Science Private Limited U24232UR2005PTC007264
Additional Director14 Sep 20062005₹88.41 Cr (FY 2025)Active
Director29 Jun 20132013₹64.4 Lakh (FY 2024)Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Utkarsh Singh

Directorship timeline

Open interactive timeline →
Balaji Pharmatech Private Limited
Fierce One Pharmaceuticals Private Limited
Shahi Emergency Hospital Private Limited
Ravian Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Utkarsh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Utkarsh Singh

Utkarsh Singh currently holds 3 directorships: Ravian Pharmaceuticals Limited (Director, since 04 Jul 2021, revenue ₹8.28 Cr (FY 2025)); Fierce One Pharmaceuticals Private Limited (Director, since 16 Dec 2021, revenue ₹3.72 Cr (FY 2024)); Balaji Pharmatech Private Limited (Director, since 18 Feb 2023, revenue ₹1.15 Cr (FY 2024)).

Utkarsh Singh was first appointed on 14 Sep 2006 as Additional Director at Ravian Life Science Private Limited. The most recent appointment on record is 18 Feb 2023 at Balaji Pharmatech Private Limited.

The 3 current companies of Utkarsh Singh that report revenue have a combined latest revenue of ₹13.16 Cr: Ravian Pharmaceuticals Limited ₹8.28 Cr (FY 2025); Fierce One Pharmaceuticals Private Limited ₹3.72 Cr (FY 2024); Balaji Pharmatech Private Limited ₹1.15 Cr (FY 2024).

Utkarsh Singh held 2 earlier board appointments: Ravian Life Science Private Limited (Additional Director, 14 Sep 2006 to 05 Nov 2022); Shahi Emergency Hospital Private Limited (Director, from 29 Jun 2013).

The current boards of Utkarsh Singh's companies include Meenakshi Singh (Ravian Pharmaceuticals Limited), Rakesh Mishra (Ravian Pharmaceuticals Limited), Vijay Kumar Shahi (Ravian Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available